FdaApplication
ANDA 212364
Identifiers
- fda_app_no: ANDA212364
Properties
| Property | Value |
|---|---|
| applicant_name | ANNORA PHARMA |
| application_type | ANDA |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EMPAGLIFLOZIN; LINAGLIPTIN | EMPAGLIFLOZIN; LINAGLIPTIN | 25MG;5MG | TABLET;ORAL |
| EMPAGLIFLOZIN; LINAGLIPTIN | EMPAGLIFLOZIN; LINAGLIPTIN | 10MG;5MG | TABLET;ORAL |
2 products